Shilpa Medicare Share Price

Overview
Recos
News
Analysis
Financials
Forecast
Technicals
Peers
Shareholdings
MF
F&O
Corp Actions
About

Shilpa Medicare Share Price

572.4019.95 (3.62%)

Closed
As On: 17 Jun, 2026, 03:59 PM IST
As On: 17 Jun, 2026, 03:56 PM IST

Sector: Pharmaceuticals
Industry: Pharma - Indian

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Try ETMarkets GPTNEW

Open	556.80
High	577.35
Low	552.50
Prev Close	552.45
Volume	13,20,326
VWAP(₹)	568.24

Key Metrics

PE Ratio(x)	46.01
EPS - TTM(₹)	12.44
MCap(₹ Cr.)	11,195.10
MCap Rank	43
PB Ratio(x)	4.17
Div Yield(%)	0.10
Face Value(₹)	1.00
52W High(₹)	581.00
52W Low(₹)	259.50
MCap/Sales	4.43
Beta(1 Month)	-0.14
BV/Share(₹)	132.49

Shilpa Medicare share price insights

Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 18.26% outperformed its 3 year CAGR of 13.06%. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent 3.82% of its operating revenues towards interest expenses and 21.76% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
Shilpa Medicare Share Price Update
Shilpa Medicare Ltd. share price moved up by 3.62% from its previous close of Rs 552.45. Shilpa Medicare Ltd. stock last traded price is 572.40
Share Price Value
Today/Current/Last 572.40572.85
Previous Day 552.45554.20

Found Insights useful?

Shilpa Medicare Share Price Returns

1 Day	3.62%
1 Month	19.65%
3 Months	80.06%
1 Year	22.52%
3 Years	385.91%
5 Years	121.95%

Shilpa Medicare Share Recommendations

Mean recosCurrent

STRONG BUY

2 Analysts

Strong
SellSellHoldBuyStrong
Buy

Analyst Trends

Ratings	Current	1W Ago	1M Ago	3M Ago
Strong Buy	2	2	1	2
Buy	-	-	-	-
Hold	-	-	-	-
Sell	-	-	-	-
Strong Sell	-	-	-	-
# Analysts	2	2	1	2

Recent Recos

Target₹540
OrganizationAnand Rathi
BUY

Target₹346
OrganizationICICI Securities
REDUCE

Target₹605
OrganizationYes Securities
BUY

View all Stock Recommendations

News & Analysis

View all Shilpa Medicare Share News & Announcements

Share Analysis

EARNINGS

FUNDAMENTAL

RELATIVE VALUATION

RISK

PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

Score on 10-point scale
Ratings by analysts
Stock performance

JOIN ET PRIME

Financials

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	438.66	410.54	371.72	327.84	338.38
Total Income Growth (%)	6.85	10.44	13.39	-3.12	5.60
Total Expenses	322.87	338.65	291.51	258.74	310.91
Total Expenses Growth (%)	-4.66	16.17	12.66	-16.78	16.26
EBIT	115.79	71.89	80.21	69.09	27.47
EBIT Growth (%)	61.07	-10.38	16.09	151.54	-48.19
Profit after Tax (PAT)	107.79	44.58	44.07	46.89	14.51
PAT Growth (%)	141.78	1.17	-6.01	223.15	-54.35
EBIT Margin (%)	26.40	17.51	21.58	21.08	8.12
Net Profit Margin (%)	24.57	10.86	11.85	14.30	4.29
Basic EPS (₹)	5.51	2.36	2.25	4.79	1.48

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	208.00	176.99	151.88	110.22	140.24
Total Income Growth (%)	17.52	16.54	37.79	-21.40	-1.39
Total Expenses	127.37	150.46	110.51	93.21	147.58
Total Expenses Growth (%)	-15.35	36.16	18.56	-36.84	27.77
EBIT	80.63	26.53	41.37	17.02	-7.34
EBIT Growth (%)	203.93	-35.87	143.11	-	-127.49
Profit after Tax (PAT)	70.96	15.93	30.83	20.70	-5.15
PAT Growth (%)	345.32	-48.31	48.95	-	-131.97
EBIT Margin (%)	38.76	14.99	27.24	15.44	-5.23
Net Profit Margin (%)	34.12	9.00	20.30	18.78	-3.68
Basic EPS (₹)	3.63	0.84	1.58	2.12	-0.53

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	1,548.71	1,309.57	1,159.77	1,067.51	1,159.77
Total Revenue Growth (%)	18.26	12.92	8.64	-7.95	24.54
Total Expenses	1,282.67	1,157.89	1,106.79	1,101.98	1,062.63
Total Expenses Growth (%)	10.78	4.62	0.44	3.70	33.61
Profit after Tax (PAT)	243.33	78.29	31.87	-32.48	60.66
PAT Growth (%)	210.79	145.63	-	-153.54	-58.95
Operating Profit Margin (%)	21.10	17.66	12.57	2.30	12.07
Net Profit Margin (%)	15.81	6.08	2.76	-3.09	5.29
Basic EPS (₹)	12.44	8.04	3.67	-3.74	7.26

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	635.17	561.18	398.90	316.35	397.81
Total Revenue Growth (%)	13.19	40.68	26.10	-20.48	37.51
Total Expenses	506.48	408.20	350.36	359.08	379.14
Total Expenses Growth (%)	24.08	16.51	-2.43	-5.29	50.43
Profit after Tax (PAT)	132.97	69.80	26.94	57.19	140.99
PAT Growth (%)	90.49	159.13	-52.90	-59.43	-23.54
Operating Profit Margin (%)	23.23	33.43	21.23	-8.84	7.76
Net Profit Margin (%)	22.27	14.62	8.69	23.08	39.49
Basic EPS (₹)	6.80	7.16	3.10	6.59	16.24

All figures in Rs Cr, unless mentioned otherwise

Insights

Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 18.26% outperformed its 3 year CAGR of 13.06%. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent 3.82% of its operating revenues towards interest expenses and 21.76% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	3,705.61	3,310.71	3,093.20	2,902.38	2,875.50
Total Assets Growth (%)	11.93	7.03	6.57	0.93	9.02
Total Liabilities	1,114.41	947.01	1,293.25	1,128.03	1,064.35
Total Liabilities Growth (%)	17.68	-26.77	14.65	5.98	-9.03
Total Equity	2,591.20	2,363.70	1,799.96	1,774.36	1,811.15
Total Equity Growth (%)	9.62	31.32	1.44	-2.03	23.42
Current Ratio (x)	1.31	1.46	1.26	0.98	1.45
Total Debt to Equity (x)	0.25	0.25	0.52	0.45	0.37
Contingent Liabilities	0.00	76.22	95.55	186.39	103.86

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	3,028.55	3,006.66	2,418.58	2,517.36	2,896.12
Total Assets Growth (%)	0.73	24.32	-3.92	-13.08	15.04
Total Liabilities	315.17	306.07	275.87	399.77	830.45
Total Liabilities Growth (%)	2.97	10.95	-30.99	-51.86	-5.58
Total Equity	2,713.38	2,700.59	2,142.72	2,117.58	2,065.67
Total Equity Growth (%)	0.47	26.04	1.19	2.51	26.12
Current Ratio (x)	1.90	2.10	1.67	2.63	1.94
Total Debt to Equity (x)	0.05	0.04	0.07	0.14	0.09
Contingent Liabilities	0.00	502.56	655.24	510.05	374.38

All figures in Rs Cr, unless mentioned otherwise

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	342.18	132.18	135.34	226.17	105.13
Net Cash used in Investing Activities	-325.92	-199.08	-166.58	-278.48	-285.50
Net Cash flow from Financing Activities	13.62	62.65	46.78	45.80	82.86
Net Cash Flow	16.61	-3.23	11.35	-6.51	-97.51
Closing Cash & Cash Equivalent	45.18	28.52	30.43	18.83	25.34
Closing Cash & Cash Equivalent Growth (%)	58.39	-6.25	61.62	-25.71	-79.46
Total Debt/ CFO (x)	1.92	4.44	6.91	3.52	6.49

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	60.00	-19.06	8.03	2.08	173.87
Net Cash used in Investing Activities	-67.15	-433.29	155.82	-94.80	-378.97
Net Cash flow from Financing Activities	13.76	450.09	-163.07	87.68	97.23
Net Cash Flow	6.11	-0.04	0.78	-5.04	-107.88
Closing Cash & Cash Equivalent	10.87	4.42	3.13	2.10	7.13
Closing Cash & Cash Equivalent Growth (%)	145.87	41.40	48.98	-70.58	-93.80
Total Debt/ CFO (x)	2.17	-5.61	17.74	138.11	1.12

All figures in Rs Cr, unless mentioned otherwise

Insights

Increase in Cash from Investing
Company has used Rs 325.92 cr for investing activities which is an YoY increase of 63.71%. (Source: Consolidated Financials)

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	9.39	3.30	1.76	-1.82	3.32
Return on Capital Employed (%)	11.36	8.61	6.03	1.14	6.10
Return on Assets (%)	6.56	2.36	1.03	-1.11	2.10
Interest Coverage Ratio (x)	7.56	4.50	2.75	2.04	5.30
Asset Turnover Ratio (x)	0.44	0.40	0.38	0.36	0.13
Price to Earnings (x)	28.09	83.33	126.58	-61.35	57.14
Price to Book (x)	2.63	2.73	2.21	1.12	1.89
EV/EBITDA (x)	16.72	20.67	19.40	23.03	18.73
EBITDA Margin (%)	28.88	26.44	21.94	11.39	19.03

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	4.90	2.58	1.25	2.70	6.82
Return on Capital Employed (%)	5.04	5.74	3.00	-0.96	1.21
Return on Assets (%)	4.39	2.32	1.11	2.27	4.86
Interest Coverage Ratio (x)	19.31	31.56	6.69	1.18	6.91
Asset Turnover Ratio (x)	0.20	0.18	0.13	0.09	0.13
Price to Earnings (x)	51.55	93.46	149.25	34.84	24.51
Price to Book (x)	2.51	2.40	1.87	0.94	1.67
EV/EBITDA (x)	35.80	31.60	35.91	92.25	57.96
EBITDA Margin (%)	32.46	43.66	37.25	9.94	17.52

Found Financials useful?

Share Price Forecast

Exclusively for ETPrime

REVENUE
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP
EARNINGS
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP
PRICE
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP

Technicals

Buy/Sell Signals
No Data Available
Price Analysis
41%
Positive Movement
since 1st Jan 2005
on basis
58%
Negative Movement
since 1st Jan 2005
on basis
Exclude
Global Meltdown1st Jan 2008 to 10th Nov 2008
Covid Crisis1st Feb 2020 to 31st Mar 2020
Pivot Levels
R1 - Pivot
-
S1 -
R2 - S2 -
R3 - S3 -
Average True Range
5 Days 14 Days 28 Days
- - -

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Shilpa Medicare	46.01	4.32	9.39	11.36	6.56	13.06	21.10	14.69	12.44	1.31	0.25	1.92
Glenmark Life	22.85	3.87	16.94	22.51	14.17	5.99	30.65	22.12	45.99	5.21	0.00	0.00
Indegene	30.99	3.96	12.77	15.97	8.68	14.70	16.08	11.42	16.72	2.41	0.00	0.00
Marksans Pharma	27.62	3.78	13.82	17.53	10.82	16.46	19.81	14.23	9.22	5.17	0.01	0.06
Corona Remedies Ltd.	59.22	14.68	24.78	31.54	15.36	16.45	18.97	13.19	30.27	0.96	0.19	0.62
Add More

Annual Ratios (%)

Choose from Peers

Sequent Scientific
Strides Shasun
Sudeep Pharma Ltd.
Akums Drugs & Pharmaceuticals Ltd.
Blue Jet Healthcare

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

Shareholding Pattern

Total Shareholdings

Category	No. of Shares	Percentage	% Change QoQ
Promoters	7,84,96,648	40.13 %	0.00
Pledge	68,50,000	8.73 %	0.00
FII	2,16,65,084	11.07 %	0.10
DII	1,67,78,556	8.58 %	0.24
MF	1,00,64,819	5.15 %	-0.04
Others	7,86,41,528	40.22 %	-0.34

QoQ Change
Category Mar 2026 Dec 2025 Sep 2025 Jun 2025
Promoters 40.13 40.13 44.23 44.23
Pledge 8.73 8.73 7.92 7.92
FII 11.07 10.96 10.92 11.19
DII 8.58 8.34 7.64 7.43
Mutual Funds 5.15 5.20 4.26 4.05
Others 40.22 40.56 37.21 37.15

Mutual Funds Ownership

MF Ownership as on 31 May 2026

Bandhan Small Cap Direct-G
Equity: Small Cap
5
- 116.59
  Amount Invested (in Cr.)
- 0.43%
  % of AUM
- -7.57
  % Change (MoM basis)
ICICI Pru ELSS Tax Saver Direct-G
Equity: ELSS
3
- 103.08
  Amount Invested (in Cr.)
- 0.75584578%
  % of AUM
- 0.00
  % Change (MoM basis)
HDFC Pharma And Healthcare Direct-G
Equity: Sectoral-Pharma
- 53.92
  Amount Invested (in Cr.)
- 2.28%
  % of AUM
- 0.00
  % Change (MoM basis)

View all Mutual Fund Schemes

Shilpa Medicare Top Searches

Corporate Actions

Recent
General Meeting
-
May 22, 2026
Final
60%
May 22, 2026
Board Meeting
Audited Results & Dividend
May 14, 2026

Announced on	Meeting on
May 14, 2026	May 22, 2026
Audited Results & Dividend
Jan 30, 2026	Feb 06, 2026
Quarterly Results
Nov 06, 2025	Nov 13, 2025
Quarterly Results
Aug 05, 2025	Aug 13, 2025
Quarterly Results
May 19, 2025	May 26, 2025
Audited Results & Final Dividend

Dividends
Announced on Ex-Date Dividend%
May 26, 2025 Sep 17, 2025 100%
May 23, 2022 Sep 19, 2022 110%
May 31, 2021 Sep 20, 2021 110%
Mar 03, 2020 Mar 16, 2020 110%
May 22, 2026 - 60%
Bonus
Announced on Ex-Date
Aug 13, 2025 Oct 03, 2025
Bonus Ratio: 1 share(s) for every 1 shares held
May 29, 2013 Jul 16, 2013
Bonus Ratio: 1 share(s) for every 2 shares held
Splits
Announced on Ex-Date
Aug 12, 2015 Nov 06, 2015
Split: Old FV2.0| New FV:1.0
Apr 26, 2007 Sep 28, 2007
Split: Old FV10.0| New FV:2.0
Rights
No Data Available

AGM/EGM Meetings

Announced on	Meeting on
May 22, 2026	Jun 24, 2026
-
Oct 07, 2025	Nov 10, 2025
-
Aug 26, 2025	Sep 23, 2025
-
Aug 08, 2024	-
Book closure from Sep 9, 2024 to Sep 17, 2024
Aug 08, 2024	-
Book closure from Sep 9, 2024 to Sep 17, 2024

About Shilpa Medicare

Shilpa Medicare Ltd., incorporated in the year 1987, is a Small Cap company (having a market cap of Rs 11,195.10 Crore) operating in Pharmaceuticals sector.

Shilpa Medicare Ltd. key Products/Revenue Segments include Formulations, Sale of services, Traded Goods, Power, Export Incentives for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Consolidated Total Income of Rs 438.66 Crore, up 6.85 % from last quarter Total Income of Rs 410.54 Crore and up 29.64 % from last year same quarter Total Income of Rs 338.38 Crore. Company has reported net profit after tax of Rs 89.47 Crore in latest quarter.

The company’s top management includes Mr.Omprakash Inani, Mr.Vishnukant C Bhutada, Mr.Kalakota Sharath Reddy, Dr.Anita Bandyopadhyay, Mr.Hetal Madhukant Gandhi, Dr.Kamal K Sharma, Mr.Ashraf Loutfy Abdelhamid Allam, Mr.Alpesh M Dalal, Ms.Ritu Tiwary. Company has BNPS & Associates LLP as its auditors. As on 31-03-2026, the company has a total of 19.56 Crore shares outstanding.

Shilpa Medicare Share Price Today is Rs. 572.40. On previous day, the Shilpa Medicare Share Price (NSE) closed at Rs. 532.75, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 40.13% of the stake in Shilpa Medicare shares, out of which 8.73% was pledged. On the same date, foreign institutional investors' (FII) holdings of Shilpa Medicare stocks was 11.07% as compared to 10.97% in Dec 2025 with increase of 0.1%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 8.58% as compared to 8.34% in Dec 2025 with increase of 0.24%. Out of the total DII holdings in Shilpa Medicare shares 5.15% was held by mutual funds. The rest including public held is 40.22%. Shilpa Medicare stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Shilpa Medicare Dividend: Ever since 1987, Shilpa Medicare dividends has been paid out around 23 times. As on 17 Jun, 2026, 03:59 PM IST, The overall dividend yield for Shilpa Medicare stands at 0.11%. The last dividend paid was on September 17, 2025 (Rs. 1.0). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. 12.44.

Shilpa Medicare Bonus: The most recent bonus issue had been in year October 3, 2025 around 0 years ago at 1 : 1 ratio. The first bonus issue was announced in May 2013.

Stock Forecast:
After showing 438.66 Cr. of sales and 6.85% of quarterly net profit, there have been multiple ups and downs in the Shilpa Medicare stock prices in the past few weeks. For example, Shilpa Medicare stock price on 9th of June 2026 was around Rs. 569.15. Shilpa Medicare share price now stands at an average of Rs. 572.40. Judging by last week's performance, stock is in down trend.

Shilpa Medicare has a median target price of Rs. 530.5 in 12 months by 2 analysts. They have provided a high estimate of Rs. 580.0 and low estimate of Rs. 481.0 for Shilpa Medicare share.

Historical Prices and Performance:
Shilpa Medicare, incorporated in 1987 is a Mid Cap company (with a market cap of Rs. 10804.92) operating in Pharmaceuticals sector.
The Return of Equity (ROE) in last five financial years given by Shilpa Medicare stock was 9.39%, 3.3%, 1.76%, -1.82% and 3.32% respectively.
The Shilpa Medicare share gave a 3 year return of 368.97% as compared to Nifty 50 which gave a return of 27.43%.
Shilpa Medicare announced 100.0% final dividend on September 17, 2025.

Key Metrics:
PE Ratio of Shilpa Medicare is 42.82
Prices/Sales Ratio of Shilpa Medicare is 4.43
Price/Book Ratio of Shilpa Medicare is 4.02

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Shilpa Medicare, major competitors and peers include Glenmark Life, Indegene, Marksans Pharma and Sequent Scientific. As of Dec 2025, the dividend yield of Shilpa Medicare stands at 0.11% while Glenmark Life, Indegene, Marksans Pharma and Sequent Scientific stand at 0.0%, 0.0%, 0.36% and 0.0% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at 42.82 and 4.02 respectively.

Leadership of Shilpa Medicare :
Ritu Tiwary is Co. Secretary & Compl. Officer
Alpesh M Dalal is Chief Financial Officer
Omprakash Inani is Chairman
Vishnukant C Bhutada is Managing Director
Kalakota Sharath Reddy is Whole Time Director
Hetal Madhukant Gandhi is Independent Director
Anita Bandyopadhyay is Independent Woman Director
Kamal K Sharma is Independent Director
Ashraf Loutfy Abdelhamid Allam is Addnl. & Ind.Director

Show More

Industry

Pharma - Indian

Key Indices Listed On

BSE SmallCap, BSE Healthcare, BSE AllCap, Nifty Smallcap 500, Nifty Microcap 250

Address

12-6-214/A-1,Shilpa House,Hyderabad Road,Raichur, Karnataka - 584135

Contact

info@vbshilpa.com

http://www.vbshilpa.com

Executive Leadership

OI

Omprakash Inani

Chairman

VC

Vishnukant C Bhutada

Managing Director

KS

Kalakota Sharath Reddy

Whole Time Director

AB

Anita Bandyopadhyay

Independent Woman Director

Show More

Auditors

BNPS & Associates LLP

Bohara Bhandari Bung & Associates LLP

Brahmayya & Co.

FAQs about Shilpa Medicare share

1. What is Shilpa Medicare share price and what are the returns for Shilpa Medicare share?
Shilpa Medicare share price is Rs 572.40 as on 17 Jun, 2026, 03:59 PM IST. Shilpa Medicare share price is up by 3.62% based on previous share price of Rs 532.75. Shilpa Medicare share price trend:
- Last 12 Months: Shilpa Medicare share price moved up 22.52%
- Last 3 Years: Shilpa Medicare Share price moved up by 385.91%
2. What are the returns for Shilpa Medicare share?
Return Performance of Shilpa Medicare Shares:
- 1 Week: Shilpa Medicare share price moved up by 2.43%
3. What's the market capitalization of Shilpa Medicare?
Market Capitalization of Shilpa Medicare stock is Rs 11,195.10 Cr.
4. What is 52 week high/low of Shilpa Medicare share price?
In last 52 weeks Shilpa Medicare share had a high price of Rs 581.00 and low price of Rs 259.50
5. What is the PE & PB ratio of Shilpa Medicare?
The PE ratio of Shilpa Medicare stands at 44.41, while the PB ratio is 4.17.

Top Gainers

As on 03:59 PM | 17 Jun 2026

90.36

13.21 (17.13%)

1,266.60

85.20 (7.22%)

28.20

1.88 (7.11%)

3,102.80

205.00 (7.08%)

Olectra Greentech

1,354.90

84.50 (6.66%)

Top Losers

As on 03:59 PM | 17 Jun 2026

360.95

-32.66 (-8.30%)

3,999.20

-163.20 (-3.93%)

479.20

-17.50 (-3.53%)

876.15

-31.50 (-3.48%)

967.60

-30.20 (-3.03%)

Equity Quick Links

Top Gainers
Top Losers
Hourly gainers
Hourly losers
Sensex
Nifty
NSE
BSE

Midcap stocks
Smallcap stocks
Largecap stocks
Sensex
Nifty
NSE
BSE
MCX Live

More from Markets

IPO
Stock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list

Trending in Markets

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.